Prescription Pattern
Conditions
Brief summary
General practices in the Capital Region of Denmark are offered a short educational visit and are randomized to either asthma (intervention) or another topic (control). The change in prescription pattern from before to after the visit is compared between the intervention and control group.
Detailed description
General practices in the Capital Region of Denmark are offered a short educational visit. They are randomized by address to be offered a visit about either asthma (intervention) or another topic (control). The prescription pattern of each general practice (as seen by their regional registration number \[ydernummer\]) who receive a visit is investigated. The change in prescription pattern from before to after the visit is compared between the intervention and control group.
Interventions
BEHAVIORALasthma education
A 15 minutes (preferable) one-on-one educational visit about asthma treatment. The main points being: Every person with asthma should be treated with inhaled corticosteroids (ICS). Most patients with asthma should be treated with Bufomix Easyhaler either as needed and/or regularly. Patients should not use short-acting bega2-agonist (SABA) unless they use a medium-ICS-dosis.
BEHAVIORALOther education
A 15 minutes (preferable) one-on-one educational visit about another topic (NOT asthma).
Sponsors
University Hospital Bispebjerg and Frederiksberg
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Intervention model description
randomized placebo controlled study
Eligibility
Sex/Gender
ALL
Healthy volunteers
Yes
Inclusion criteria
* General practices in the capital region of denmark, who owns a regional registration number \[ydernummer\] * Want a visit * Have time for a visit within the study period
Exclusion criteria
\-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Difference in change of prescription of inhaled corticosteroids and long-acting beta2-agonist (ICS+LABA) before and after educational visit in a six months period | 6-0 months before and 6-12 months after educational visit | Difference in change of number of adult patients with prescriptions on ICS+LABA between asthma-group and placebo-group. |
| Difference in change of prescription of ICS and SABA (as monotherapy) before and after educational visit in a six months period | 6-0 months before and 6-12 months after educational visit | Difference in change of number of adult patients with prescriptions on ICS and SABA as monotherapy to adults between asthma-group and placebo-group. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Difference in change of prescription of ICS+LABA before and after educational visit in one year for each month | one year before and one year after educational visit | Difference in change of number of adult patients with prescriptions on ICS+LABA between asthma-group and placebo-group analyzed by each month in relation to the visit |
| Difference in change of prescription of ICS and SABA (as monotherapy) before and after educational visit one year | one year before and one year after educational visit | Difference in change of number of adult patients with prescriptions on ICS or on SABA as monotherapy to adults between asthma-group and placebo-group. |
| Difference in change of prescription of ICS and SABA (as monotherapy) before and after educational visit one year as interrupted time series analysis | one year before and one year after educational visit | Difference in change of number of adult patients with prescriptions on ICS or on SABA as monotherapy to adults between asthma-group and placebo-group as interrupted time series analysis |
| Difference in change of prescription of ICS and SABA (as monotherapy) before and after educational visit one year for each month | one year before and one year after educational visit | Difference in change of number of adult patients with prescriptions on ICS and on SABA as monotherapy to adults between asthma-group and placebo-group analyzed by each month in relation to the visit |
| Difference in change of prescription of the Easyhaler Device before and after educational visit in a six months period | 6-0 months before and 6-12 months after educational visit | Difference in change of number of adult patients with prescription on the Easyhaler Device between asthma-group and placebo-group |
| Difference in change of prescription of the Easyhaler Device before and after educational visit in one year | one year before and one year after educational visit | Difference in change of number of adult patients with prescription on the Easyhaler Device between asthma-group and placebo-group |
| Difference in change of prescription of the Easyhaler Device before and after educational visit as interrupted time series analysis | one year before and one year after educational visit | Difference in change of number of adult patients with prescription on the Easyhaler Device between asthma-group and placebo-group as interrupted time series analysis |
| Difference in change of prescription of the Easyhaler Device before and after educational visit for each month | one year before and one year after educational visit | Difference in change of number of adult patients with prescription on the Easyhaler Device between asthma-group and placebo-group analyzed by each month in relation to the visit |
| Difference in change of prescription of ICS+LABA before and after educational visit in one year | one year before and one year after educational visit | Difference in change of number of adult patients with prescriptions on ICS+LABA between asthma-group and placebo-group |
| Difference in change of prescription of LAMA before and after educational visit in one year | one year before and one year after educational visit | Difference in change of number of adult patients with prescription on LAMA between asthma-group and placebo-group |
| Difference in change of prescription of LAMA before and after educational visit as interrupted time series analysis | one year before and one year after educational visit | Difference in change of number of adult patients with prescription on LAMA between asthma-group and placebo-group |
| Difference in change of prescription of LAMA before and after educational visit for each month | one year before and one year after educational visit | Difference in change of number of adult patients with prescription on LAMA between asthma-group and placebo-group analyzed by each month in relation to the visit |
| Difference in change of cost of each medication group before and after educational visit in a six months period | 6-0 months before and 6-12 months after educational visit | Difference in change of cost (pharmacy retail price) of SABA, ICS, ICS+LABA, LAMA and ICS+LAMA+LABA to adults between asthma-group and placebo-group |
| Difference in change of cost of each medication group before and after educational visit in one year | one year before and one year after educational visit | Difference in change of cost (pharmacy retail price) of SABA, ICS, ICS+LABA, LAMA and ICS+LAMA+LABA to adults between asthma-group and placebo-group |
| Difference in change of cost of each medication group before and after educational visit as interrupted time series analysis | one year before and one year after educational visit | Difference in change of cost (pharmacy retail price) of SABA, ICS, ICS+LABA, LAMA and ICS+LAMA+LABA to adults between asthma-group and placebo-group |
| Difference in change of cost of each medication group before and after educational visit for each month | one year before and one year after educational visit | Difference in change of cost (pharmacy retail price) of SABA, ICS, ICS+LABA, LAMA and ICS+LAMA+LABA to adults between asthma-group and placebo-group analyzed by each month in relation to the visit |
| Difference in change of prescription of long-acting muscarinic antagonist (LAMA) before and after educational visit in a six months period | 6-0 months before and 6-12 months after educational visit | Difference in change of number of adult patients with prescription on LAMA between asthma-group and placebo-group |
| Difference in change of prescription of ICS+LABA before and after educational visit in one year as interrupted time series analysis | one year before and one year after educational visit | Difference in change of number of adult patients with prescriptions on ICS+LABA between asthma-group and placebo-group as interrupted time series analysis |
Countries
Denmark
Contacts
Primary ContactJon T. T. Andersen, MD
Backup ContactDagmar A Dalin, Cand. Pharm.
Outcome results
None listed